2026 ICD-10-CM Diagnosis Code I73.89Other specified peripheral vascular diseases

ICD-10-CM CodesI00–I99I70-I79I73

ICD-10-CM I73.89
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

I73.89 is a billable ICD-10-CM diagnosis code for other specified peripheral vascular diseases. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 299 through 301. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Peripheral and visceral vascular disease.

Code Identity

ICD-10-CM Code
I73.89
Billable Status
Yes — Valid for Submission
Code Describes
Other specified peripheral vascular diseases
Short Description
Other specified peripheral vascular diseases
Same as the full description in the CMS dataset.
Parent Code
Other specified peripheral vascular diseases

Code Classification

ChapterI00–I99Diseases of the circulatory system
SectionI70-I79Diseases of arteries, arterioles and capillaries
CategoryI73Other peripheral vascular diseases
This CodeI73.89Other specified peripheral vascular diseases

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Abnormal vasomotor function
  • Acrocyanosis
  • Acroparesthesia
  • Angiodyskinesia
  • Arterial steal syndrome
  • Arteriovenous malformation of kidney
  • Bad circulation - vasomotor change
  • Cocaine-induced acrocyanosis and livedo reticularis
  • Critical upper limb ischemia
  • Cutaneous collagenous vasculopathy
  • Diffuse palmoplantar keratoderma and acrocyanosis syndrome
  • Edema due to disturbed vasomotor control
  • Erythema induratum
  • Erythrocyanosis
  • Erythrocyanosis with nodules
  • Hypothenar hammer syndrome
  • Ischemia of left lower extremity
  • Ischemia of left upper limb
  • Ischemia of right lower extremity
  • Ischemia of right upper limb
  • Lobular panniculitis
  • Localized cutaneous vasculitis
  • Nodular vasculitis
  • Peripheral cyanosis
  • Simple acroparesthesia
  • Skin lesion in drug addict
  • Steal syndrome of lower limb
  • Steal syndrome of upper limb
  • Upper limb ischemia
  • Vascular insufficiency of kidney
  • Vasoconstriction disorder of extremities
  • Vasodilatation
  • Vasodilatation disorder of extremities
  • Vasomotor acroparesthesia
  • Vasomotor arterial disorder
  • Vasomotor hypotonia
  • Vibration syndrome
  • Vibration white finger

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Acrocyanosis
  • Erythrocyanosis
  • Simple acroparesthesia Schultze's type
  • Vasomotor acroparesthesia Nothnagel's type

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Acroasphyxia, chronic
    • Acrocyanosis
    • Acroparesthesia(simple) (vasomotor)
    • Angiopathia, angiopathy
      • peripheral
        • specified type NEC
    • Crocq's disease(acrocyanosis)
    • Disease, diseased
      • Crocq's (acrocyanosis)
    • Erythrocyanosis(crurum)
    • Nothnagel's
      • vasomotor acroparesthesia
    • Schultze's type acroparesthesia, simple
    • Syndrome
      • hypothenar hammer
    • Syndrome
      • Nothnagel's vasomotor acroparesthesia

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR CIR026
Peripheral and visceral vascular disease
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Erythema Induratum

    a type of panniculitis characterized histologically by the presence of granulomas, vasculitis, and necrosis. it is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. it is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. the nodules may progress to form indurations, ulcerations, and scars.
  • Acrocyanosis

    persistent, symmetric, and painless blue discoloration of the extremities. it is the result of vasospasm in response to cold. the affected areas are cold and sweaty.
  • Neonatal Acrocyanosis

    transient cyanotic discoloration of the hands and feet, especially fingers and toes, in a newborn.

Convert I73.89 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
443.89 Periph vascular dis NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About I73.89Overview

Is I73.89 (Other specified peripheral vascular diseases) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other specified peripheral vascular diseases on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does I73.89 group to?

When other specified peripheral vascular diseases is the principal diagnosis on an inpatient stay, it groups to MS-DRG 299, 300, 301, with relative weights from 0.7197 to 1.6327 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of I73.89?

Under the General Equivalence Mappings, other specified peripheral vascular diseases converts to ICD-9-CM 443.89 (periph vascular dis NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.